Related Experiment Video
Updated: Mar 31, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Comparative effects of 1.25 vs. 1.5 mmol/L dialysate calcium concentrations on blood pressure variability during
Daqing Hong1,2,3, Changlian Li4,5, Yun Zhang6
1Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Insights
Lowering dialysate calcium concentration during hemodialysis significantly reduces blood pressure variability (BPV). This suggests a strategy to improve hemodynamic stability and patient outcomes in dialysis patients.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Clinical Chemistry
Background:
- Blood pressure fluctuations in hemodialysis patients are linked to adverse cardiovascular events.
- The optimal dialysate calcium concentration for managing blood pressure variability (BPV) is debated.
Purpose of the Study:
- To compare the effects of two dialysate calcium concentrations (1.25 mmol/L vs. 1.5 mmol/L) on intradialytic blood pressure variability.
- To identify the optimal dialysate calcium concentration for minimizing BPV in hemodialysis patients.
Main Methods:
- Retrospective cohort study analyzing 2,061 hemodialysis sessions from 711 patients.
- Patients were divided into two groups based on dialysate calcium: 1.25 mmol/L (n=473) and 1.5 mmol/L (n=238).
- Blood pressure variability was defined as the difference between maximum and minimum blood pressure during dialysis.
Main Results:
- The 1.25 mmol/L group showed significantly lower systolic (SBPV), diastolic (DBPV), and mean arterial pressure variability (MAPV) compared to the 1.5 mmol/L group (p < 0.001 for all).
- Smaller serum total calcium changes occurred in the 1.25 mmol/L group, correlating positively with SBPV and MAPV.
- Higher dialysate calcium (1.5 mmol/L) was independently associated with greater BPV after adjusting for confounders.
Conclusions:
- Lowering dialysate calcium concentration to 1.25 mmol/L may enhance hemodynamic stability during hemodialysis.
- Minimizing calcium flux through lower dialysate calcium concentrations could reduce blood pressure fluctuations.
Introduction:
Hemodialysis patients frequently experience blood pressure fluctuations, which are independently associated with adverse cardiovascular outcomes. However, the optimal dialysate calcium concentration for minimizing blood pressure variability (BPV) remains controversial.
Methods:
This retrospective cohort study investigated the differential effects of dialysate calcium concentrations of 1.25 mmol/L (DCa 1.25) versus 1.5 mmol/L (DCa 1.5) on intradialytic BPV. We analyzed 2,061 hemodialysis sessions from 711 maintenance hemodialysis patients across two centers in China. Patients were categorized based on dialysate calcium concentration: 1.25 mmol/L (n = 473 patients, 1,425 sessions) and 1.5 mmol/L (n = 238 patients, 636 sessions). BPV was defined as the difference between maximum and minimum blood pressure during each session.
Results:
Compared with DCa 1.5, group DCa 1.25 demonstrated significantly lower systolic blood pressure variability (SBPV) (25.23 ± 14.55 vs. 32.42 ± 17.71 mmHg, p < 0.001), diastolic blood pressure variability (DBPV) (9.78 ± 8.07 vs. 11.56 ± 9.67 mmHg, p < 0.001), and mean arterial pressure variability (MAPV) (15.41 ± 9.40 vs. 18.71 ± 11.10 mmHg, p < 0.001). Serum total calcium changes during dialysis were smaller in the 1.25 mmol/L group [0.04 (-0.06, 0.16) vs. 0.15 (0.04, 0.26) mmol/L, p < 0.001] and positively correlated with SBPV and MAPV. In multivariate generalized linear models adjusted for potential confounders, dialysate calcium concentration of 1.5 mmol/L was independently associated with greater BPV.
Discussion:
These findings suggest that lower dialysate calcium concentration may improve hemodynamic stability during hemodialysis by minimizing calcium flux and associated blood pressure fluctuations.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Potassium-Sparing Diuretics
Ionic Strength: Effects on Chemical Equilibria
In this solution, the primary...

